Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Harrington, Robert
One or more keywords matched the following items that are connected to Harrington, Robert
Item TypeName
Concept Factor Xa
Academic Article Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease.
Academic Article Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
Academic Article Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.
Academic Article Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease.
Academic Article Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Academic Article Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Academic Article Apixaban with antiplatelet therapy after acute coronary syndrome.
Academic Article Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial.
Academic Article Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
Academic Article Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
Academic Article The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Academic Article Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy.
Academic Article Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
Academic Article Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.
Academic Article Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).
Academic Article Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
Academic Article Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
Academic Article Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
Academic Article Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.
Academic Article First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
Academic Article Antithrombotics in acute coronary syndromes.
Concept Factor Xa Inhibitors
Search Criteria
  • Factor Xa